No Bear Market Here: 5 U.S. Stocks Defying the Selloff

Published:

Out of the 600 U.S.-listed stocks with market caps above $5 billion, only 27 have seen a share price increase since the first day of trading in 2016. Included in today’s list are names that could be on track to become top performers in 2016.

SciVacMacys Inc. (NYSE: M) – $40.61
Department Stores

Macy’s, Inc. is an omnichannel retail company operating stores, websites (macys.com, bloomingdales.com and bluemercury.com) and mobile. The Company operates its stores under the names of Macy’s, Bloomingdale’s, Bloomingdale’s Outlet and Bluemercury.

  • Market Cap: $12,489,821,887
  • Revenue (LTM): $27,574,000,000
  • Operating Profit (LTM): $2,450,000,000
  • YTD Price Change: 13.6%

SciVacTime Warner Inc. (NYSE: TWX) – $69.48
Entertainment Production

Time Warner Inc. (Time Warner) is a media and entertainment company that operates in three segments: Turner, which consists of cable networks and digital media properties; Home Box Office, which consists of domestic premium pay television services, and international premium pay and basic tier television services, and Warner Bros., which consists of television, feature film, home video and videogame production and distribution of digital and physical home entertainment products. Turner operates over 165 channels globally. In the United States, its networks and related properties include TNT, TBS, Adult Swim, truTV, Turner Classic Movies, Turner Sports, Cartoon Network, Boomerang, CNN and HLN.

  • Market Cap: $55,084,174,687
  • Revenue (LTM): $28,564,000,000
  • Operating Profit (LTM): $6,868,000,000
  • YTD Price Change: 6.5%

SciVacConsolidated Edison Inc. (NYSE: ED) – $67.69
Electric Utilities

Consolidated Edison, Inc. (Con Edison) is a holding company that operates through its subsidiaries, which include Consolidated Edison Company of New York, Inc. (CECONY), Orange and Rockland Utilities, Inc. (O&R) and the Competitive Energy Businesses. CECONY delivers electricity, natural gas and steam to customers in New York City and Westchester County.

  • Market Cap: $20,010,371,609
  • Revenue (LTM): $12,675,000,000
  • Operating Profit (LTM): $2,278,000,000
  • YTD Price Change: 6.2%

SciVacHasbro Inc. (NASDAQ: HAS) – $71.95
Toys & Juvenile Products

Hasbro, Inc. (Hasbro), through its wholly-owned Hasbro Studios LLC (Hasbro Studios), creates entertainment brand storytelling across mediums, including television, film and among others. Its brand blueprint involves re-imagining, re-inventing, and re-igniting its owned and controlled brands, and imagining, inventing and igniting new brands, through toy and game innovation, immersive entertainment offerings, including television programming and motion pictures, and a range of products, ranging from traditional to digital.

  • Market Cap: $8,690,000,420
  • Revenue (LTM): $4,280,748,000
  • Operating Profit (LTM): $656,781,000
  • YTD Price Change: 3.5%

SciVacBaxalta Inc. (NYSE: BXLT) – $40.69
Pharmaceuticals

Baxalta Incorporated is a biopharmaceutical company that develops, manufactures and markets a portfolio of treatments for hemophilia and other bleeding disorders, immune deficiencies, alpha-1 antitrypsin deficiency, burns and shock, and other chronic and acute medical conditions. The Company also focuses on disease areas, including oncology, as well as technology platforms, including gene therapy and biosimilars. The Company has a portfolio of various therapies that address unmet medical needs across various disease areas, including hemophilia, immunology and oncology.

  • Market Cap: $27,309,125,015
  • Revenue (LTM): $6,068,000,000
  • Operating Profit (LTM): $1,475,000,000
  • YTD Price Change: 3.1%

DISCLAIMER
The Content contained on this page (including any facts, views, opinions, recommendations, description of, or references to, products or securities) made available by SmallCapPower/Ubika Research is for information purposes only and is not tailored to the needs or circumstances of any particular person. Any mention of a particular security is merely a general discussion of the merits and risks associated there with and is not to be used or construed as an offer to sell, a solicitation of an offer to buy, or an endorsement, recommendation, or sponsorship of any entity or security by SmallCapPower/Ubika Research. The Reader should apply his/her own judgment in making any use of any Content, including, without limitation, the use of any information contained therein as the basis for any conclusions. The Reader bears responsibility for his/her own investment research and decisions. Before making any investment decision, it is strongly recommended that you seek outside advice from a qualified investment advisor. SmallCapPower/Ubika Research does not provide or guarantee any financial, legal, tax, or accounting advice or advice regarding the suitability, profitability, or potential value of any particular investment, security, or information source.

Related articles

Recent articles